Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 1822K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Girardi, G. Articles by Salmon, J. E. Search for Related Content PubMed PubMed Citation Articles by Girardi, G. Articles by Salmon, J. E. Related Collections Related Article Social Bookmarking                      What's this?

¹ Autoimmunity and Inflammation Program, Hospital for Special Surgery, Weill Medical College, Cornell University, New York, NY 10021
² Department of Medicine and Department of Immunology, University of Colorado Health Sciences Center, Denver, CO 80262

CORRESPONDENCE Jane E. Salmon: salmonj{at}hss.edu

Immune mechanisms have been implicated in placental dysfunction in patients with recurrent miscarriages and intrauterine growth restriction (IUGR), but the mediators are undefined. Here we show that complement activation, particularly C5a, is a required intermediary event in the pathogenesis of placental and fetal injury in an antibody-independent mouse model of spontaneous miscarriage and IUGR, and that complement activation causes dysregulation of the angiogenic factors required for normal placental development. Pregnancies complicated by miscarriage or growth restriction were characterized by inflammatory infiltrates in placentas, functional deficiency of free vascular endothelial growth factor (VEGF), elevated levels of soluble VEGF receptor 1 (sVEGFR-1, also known as sFlt-1; a potent anti-angiogenic molecule), and defective placental development. Inhibition of complement activation in vivo blocked the increase in sVEGFR-1 and rescued pregnancies. In vitro stimulation of monocytes with products of the complement cascade directly triggered release of sVEGFR-1, which sequesters VEGF. These studies provide the first evidence linking the complement system to angiogenic factor imbalance associated with placental dysfunction, and identify a new effector of immune-triggered pregnancy complications.

Abbreviations used: Crry, complement receptor 1–related gene/protein y; HRP, horseradish peroxidase; IC, immune complex; IUGR, intrauterine growth restriction; PEG sTNFRI, polyethylene glycol–conjugated soluble TNF- receptor type I; sVEGFR-1, soluble vascular endothelial growth factor receptor 1; VEGF, vascular endothelial growth factor; VEGFR-1, VEGF receptor 1.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Complement complicates pregnancies

Heather L. Van Epps
J. Exp. Med. 2006 203: 2045. [Full Text] [PDF]

This article has been cited by other articles:

• Nielsen, H. S., Steffensen, R., Varming, K., Van Halteren, A. G.S., Spierings, E., Ryder, L. P., Goulmy, E., Christiansen, O. B. (2009). Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy. Hum Mol Genet 18: 1684-1691 [Abstract] [Full Text]  
• Murphy, S. P., Tayade, C., Ashkar, A. A., Hatta, K., Zhang, J., Croy, B. A. (2009). Interferon Gamma in Successful Pregnancies. Biol. Reprod. 80: 848-859 [Abstract] [Full Text]  
• Redecha, P., van Rooijen, N., Torry, D., Girardi, G. (2009). Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 113: 4101-4109 [Abstract] [Full Text]  
• Herse, F., Verlohren, S., Wenzel, K., Pape, J., Muller, D. N., Modrow, S., Wallukat, G., Luft, F. C., Redman, C. W.G., Dechend, R. (2009). Prevalence of Agonistic Autoantibodies Against the Angiotensin II Type 1 Receptor and Soluble fms-Like Tyrosine Kinase 1 in a Gestational Age-Matched Case Study. Hypertension 53: 393-398 [Abstract] [Full Text]  
• Fakhouri, F., Jablonski, M., Lepercq, J., Blouin, J., Benachi, A., Hourmant, M., Pirson, Y., Durrbach, A., Grunfeld, J.-P., Knebelmann, B., Fremeaux-Bacchi, V. (2008). Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome. Blood 112: 4542-4545 [Abstract] [Full Text]  
• Franchi, A., Zaret, J., Zhang, X., Bocca, S., Oehninger, S. (2008). Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium. Mol Hum Reprod 14: 413-421 [Abstract] [Full Text]  
• Salmon, J., de Groot, P. (2008). Pathogenic role of antiphospholipid antibodies. Lupus 17: 405-411 [Abstract]  
• Zhou, C. C., Ahmad, S., Mi, T., Abbasi, S., Xia, L., Day, M.-C., Ramin, S. M., Ahmed, A., Kellems, R. E., Xia, Y. (2008). Autoantibody From Women With Preeclampsia Induces Soluble Fms-Like Tyrosine Kinase-1 Production via Angiotensin Type 1 Receptor and Calcineurin/Nuclear Factor of Activated T-Cells Signaling. Hypertension 51: 1010-1019 [Abstract] [Full Text]  
• Peng, Q., Li, K., Anderson, K., Farrar, C. A., Lu, B., Smith, R. A. G., Sacks, S. H., Zhou, W. (2008). Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 111: 2452-2461 [Abstract] [Full Text]  
• Hering, L., Herse, F., Verlohren, S., Park, J.-K., Wellner, M., Qadri, F., Pijnenborg, R., Staff, A. C., Huppertz, B., Muller, D. N., Luft, F. C., Dechend, R. (2008). Trophoblasts Reduce the Vascular Smooth Muscle Cell Proatherogenic Response. Hypertension 51: 554-559 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS